1. Home
  2. MXCT vs DGICA Comparison

MXCT vs DGICA Comparison

Compare MXCT & DGICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • DGICA
  • Stock Information
  • Founded
  • MXCT 1999
  • DGICA 1986
  • Country
  • MXCT United States
  • DGICA United States
  • Employees
  • MXCT N/A
  • DGICA N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DGICA Property-Casualty Insurers
  • Sector
  • MXCT Health Care
  • DGICA Finance
  • Exchange
  • MXCT Nasdaq
  • DGICA Nasdaq
  • Market Cap
  • MXCT 534.8M
  • DGICA 516.7M
  • IPO Year
  • MXCT 2021
  • DGICA N/A
  • Fundamental
  • Price
  • MXCT $5.05
  • DGICA $14.43
  • Analyst Decision
  • MXCT Strong Buy
  • DGICA
  • Analyst Count
  • MXCT 2
  • DGICA 0
  • Target Price
  • MXCT $9.50
  • DGICA N/A
  • AVG Volume (30 Days)
  • MXCT 565.6K
  • DGICA 78.1K
  • Earning Date
  • MXCT 03-11-2025
  • DGICA 02-20-2025
  • Dividend Yield
  • MXCT N/A
  • DGICA 4.70%
  • EPS Growth
  • MXCT N/A
  • DGICA 148.60
  • EPS
  • MXCT N/A
  • DGICA 0.74
  • Revenue
  • MXCT $45,599,000.00
  • DGICA $979,119,004.00
  • Revenue This Year
  • MXCT N/A
  • DGICA N/A
  • Revenue Next Year
  • MXCT $21.13
  • DGICA $5.78
  • P/E Ratio
  • MXCT N/A
  • DGICA $19.71
  • Revenue Growth
  • MXCT 19.85
  • DGICA 7.44
  • 52 Week Low
  • MXCT $3.17
  • DGICA $12.26
  • 52 Week High
  • MXCT $5.29
  • DGICA $17.00
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 66.94
  • DGICA 31.02
  • Support Level
  • MXCT $4.64
  • DGICA $14.17
  • Resistance Level
  • MXCT $5.20
  • DGICA $14.81
  • Average True Range (ATR)
  • MXCT 0.30
  • DGICA 0.28
  • MACD
  • MXCT 0.05
  • DGICA -0.01
  • Stochastic Oscillator
  • MXCT 88.19
  • DGICA 23.78

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About DGICA Donegal Group Inc.

Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.

Share on Social Networks: